Related Experiment Videos
Cardiomyopathies and their role in sudden death
Journal of the American College of Cardiology
|June 1, 1985
Summary
Sudden death is common in hypertrophic cardiomyopathy and dilated cardiomyopathy, often preceded by ventricular arrhythmias. Myocardial changes like hypertrophy and fibrosis are key substrates for these dangerous heart rhythm disturbances.
Area of Science:
- Cardiology
- Electrophysiology
- Pathology
Background:
- Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) share risks for sudden cardiac death.
- Ventricular arrhythmias, including premature complexes and tachycardia, are common in both conditions.
- Sudden death is a significant concern, particularly in asymptomatic young HCM patients with a family history.
Purpose of the Study:
- To investigate the substrates and mechanisms underlying ventricular arrhythmias and sudden death in HCM and DCM.
- To identify factors contributing to the high incidence of sudden death in HCM patients.
Main Methods:
- Comparative analysis of clinical and pathological findings in HCM and DCM patients.
- Review of factors associated with sudden cardiac death in HCM.
- Identification of myocardial structural changes related to ventricular arrhythmias.
Main Results:
- Myocardial hypertrophy and disordered cell arrangement are primary substrates for ventricular arrhythmias in HCM.
- Ventricular tachycardia leading to ventricular fibrillation is the common terminal event in sudden death.
- Myocardial hypertrophy and fibrosis are implicated as substrates for ventricular arrhythmias in DCM.
- Previous attempts to link sudden death in HCM to hemodynamic or demographic factors were unrewarding.
Conclusions:
- Ventricular arrhythmias and sudden death are significant risks in both HCM and DCM.
- Myocardial structural abnormalities are the likely cause of arrhythmias in these cardiomyopathies.
- Specific anatomical variations and acquired conditions can further increase sudden death risk in HCM.